Ads
related to: Novavax
Search results
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 3 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 3 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
Why Novavax Stock More Than Doubled Today | The Motley Fool
The Motley Fool· 3 days agoShares of Novavax (NVAX 98.66%) are up 12% as of midday Friday following the release of the...
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
Barrons.com· 3 days agoNovavax the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 3 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) delivered earnings and revenue surprises of -0.96% and 7.30%, respectively, for the...
Novavax shares surge on new $1.4 billion deal with Sanofi
Market Watch· 3 days agoNovavax NVAX shares surged 45% in Friday’s pre-market trading session having lost 50% of their value...
Why Novavax Stock More Than Doubled Today
Motley Fool via Yahoo Finance· 3 days agoShares of Novavax (NASDAQ: NVAX) are up 12% as of midday Friday following the release of the drugmaker's first-quarter results. It's not the report,...
Novavax stock soars 120% as Sanofi deal 'kicks off a new chapter' By Investing.com
Investing.com· 3 days agoNovavax (NASDAQ:NVAX) shares skyrocketed more than 120% in premarket trading Friday, driven by the...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 3 days agoFriday, Novavax Inc (NASDAQ: NVAX) entered a co-exclusive licensing agreement with Sanofi SA...